Preferred Label : Osilodrostat;
Obsolete resource : false;
MeSH note : an orally active aldosterone-synthase inhibitor;
CISMeF synonym : LCI699;
MeSH synonym : benzonitrile, 4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-; 4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-benzonitrile; ( )-Osilodrostat;
Is substance : O;
UNII : 5YL4IQ1078;
Origin ID : C553306;
UMLS CUI : C4330903;
ATC code(s)
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3265513/fr/isturisa-osilodrostat
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Osilodrostat
Osilodrostat
osilodrostat
administration, oral
adult
cushing syndrome
Endogenous Cushing Syndrome
evaluation of the transparency committee
imidazoles
pyridines
---
https://www.ema.europa.eu/en/medicines/human/EPAR/isturisa
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Osilodrostat
Osilodrostat
osilodrostat
orphan drug production
adult
cushing syndrome
administration, oral
steroid 11-beta-hydroxylase
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
imidazoles
pyridines
imidazoles
pyridines
---